PIXUVRI (PIXANTRONE) Trademark

Trademark Overview

On Monday, July 23, 2012, a trademark application was filed for PIXUVRI (PIXANTRONE) with the United States Patent and Trademark Office. The USPTO has given the PIXUVRI (PIXANTRONE) trademark a serial number of 85684304. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 12, 2016. This trademark is owned by Cell Therapeutics, Inc.. The PIXUVRI (PIXANTRONE) trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment made in significant part of pixantrone; pharmaceutical preparations used for the treatment of cancer made in significant part of pixantrone
pixuvri (pixantrone)

General Information

Serial Number85684304
Word MarkPIXUVRI (PIXANTRONE)
Filing DateMonday, July 23, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 12, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 10, 2013

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PIXANTRONE"
Description of MarkThe mark consists of the word "PIXUVRI" in which the letter "X" is represented by a stylized stick figure person, all over the word "(PIXANTRONE)".
Goods and ServicesPharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment made in significant part of pixantrone; pharmaceutical preparations used for the treatment of cancer made in significant part of pixantrone

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 30, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCTI BIOPHARMA CORP.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCell Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events

Event DateEvent Description
Monday, December 12, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 12, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 13, 2016EXTENSION 5 GRANTED
Monday, April 4, 2016EXTENSION 5 FILED
Monday, April 4, 2016TEAS EXTENSION RECEIVED
Friday, October 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 29, 2015EXTENSION 4 GRANTED
Monday, October 19, 2015EXTENSION 4 FILED
Monday, October 19, 2015TEAS EXTENSION RECEIVED
Friday, April 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 16, 2015EXTENSION 3 GRANTED
Tuesday, April 14, 2015EXTENSION 3 FILED
Tuesday, April 14, 2015TEAS EXTENSION RECEIVED
Tuesday, October 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 6, 2014EXTENSION 2 GRANTED
Tuesday, September 23, 2014EXTENSION 2 FILED
Monday, October 6, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 23, 2014TEAS EXTENSION RECEIVED
Wednesday, July 2, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, April 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 24, 2014EXTENSION 1 GRANTED
Thursday, April 24, 2014EXTENSION 1 FILED
Thursday, April 24, 2014TEAS EXTENSION RECEIVED
Thursday, April 24, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 5, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2013PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 1, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 31, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 31, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 31, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 6, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 6, 2013NON-FINAL ACTION E-MAILED
Wednesday, February 6, 2013NON-FINAL ACTION WRITTEN
Monday, February 4, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, December 30, 2012WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, December 14, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 14, 2012ASSIGNED TO LIE
Friday, November 30, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 29, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 28, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 28, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 28, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 27, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2012NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2012NON-FINAL ACTION WRITTEN
Friday, November 16, 2012ASSIGNED TO EXAMINER
Tuesday, July 31, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Monday, July 30, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 26, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

pixantrone pixuvri treatment pharmaceutical part significant preparations made used cancer chemotherapy